Pfizer Suspends Trial of Tanezumab for Arthritis Pain - BusinessWeek

Boston Globe

Pfizer Suspends Trial of Tanezumab for Arthritis Pain BusinessWeek June 23 (Bloomberg) -- Pfizer Inc., the world's biggest drugmaker, said it suspended trials of its experimental pain relief drug, ... Pfizer halts clinical trials of arthritis drugReuters Pfizer Immediately Halts Tanezumab Osteoarthritis TrialseMaxHealth Pfizer stock falls on failed late-stage testTheDay.com BNET -The Associated Press all 398 news articles »

Effects of Biofreeze pain reliever and chiropractic adjustments on acute low ... - Chiropractic Economics

Effects of Biofreeze pain reliever and chiropractic adjustments on acute low ... Chiropractic Economics Pain 1999;80(1-2):113-9. 2American College of Rheumatology. Recommendations for the medical management of osteoarthritis of the hip and knee. Arthritis ...

Nutra Pharma Begins Drug Registration Process in Central America for Its ... - MarketWatch (press release)

Nutra Pharma Begins Drug Registration Process in Central America for Its ... MarketWatch (press release) "As an important international business center, Panama offers us an opportunity to introduce our Nyloxin pain reliever in Central America," explained Rik J ... Steroid Stocks: Steroidstocks.com Lists Stocks on Steroids!!!:(OTCBB:AGRT ...Trading Markets (press release) all 14 news articles »

CareCore National Expands Expertise into Interventional Pain Management - Business Wire (press release)

CareCore National Expands Expertise into Interventional Pain Management Business Wire (press release) ... including 59 million reporting lower back pain, 30 million reporting neck pain, and one in five adults with doctor-diagnosed arthritis. ... and more »